Literature DB >> 27790072

Dosimetric influence of photon beam energy and number of arcs on volumetric modulated arc therapy in carcinoma cervix: A planning study.

Girigesh Yadav1, Manindra Bhushan1, Abhinav Dewan1, Upasna Saxena1, Lalit Kumar1, Deepika Chauhan1, Kothanda Raman1, Swarupa Mitra1, Mahammood Suhail1.   

Abstract

AIM: Aim of the present study was to compare the dosimetric impact of different photon beam energies and number of arcs in the treatment of carcinoma cervix.
BACKGROUND: Carcinoma cervix is a common cancer in women worldwide with a high morbidity rate. Radiotherapy is used to treat such tumours. Volumetric Modulated Arc Therapy (VMAT) is considered superior to other techniques with multiple arcs and energies.
MATERIALS AND METHODS: Twenty patients with carcinoma cervix underwent radiotherapy in a prospective observation study conducted at our institute. Volumetric modulated arc plans with 6 MV, 10 MV and 15 MV photon energies using single arc (SA) and dual arc (DA) were generated. Several physical indices for planning target volume (PTV) like V95%, V100%, V110%, D98%, D50%, D2% and total number of MUs were compared. Normal Tissue Integral Dose (NTID) and dose to a shell structure PHY2.5 and PHY5.0 were analyzed.
RESULTS: Comparable dose coverage to PTV was observed for all the energies and arcs. CI for DA6MV (1.095) was better than SA6MV (1.127), SA10MV (1.116) and SA15MV (1.116). Evaluated parameters showed significant reduction in OAR doses. Mean bladder dose for DA6MV (41.90 Gy) was better than SA6MV (42.48 Gy), SA10MV (42.08 Gy) and SA15MV (41.93 Gy). Similarly, p-value for the mean rectal dose calculated was 0.001 (SA6 vs 15), 0.013 (DA6 vs 10) and 0.003 (DA6 vs 15) and subsequently favoured DA6MV. Difference in NTID was very small.
CONCLUSIONS: The study showed no greater advantage of higher energy, and DA VMAT plan with 6 MV photon energy was a good choice of treatment for carcinoma cervix as it delivered a highly homogeneous and conformal plan with superior target coverage and better OAR sparing.

Entities:  

Keywords:  Carcinoma cervix; Conformity index; Dual arc; NTID; Photon energy; VMAT

Year:  2016        PMID: 27790072      PMCID: PMC5071544          DOI: 10.1016/j.rpor.2016.09.002

Source DB:  PubMed          Journal:  Rep Pract Oncol Radiother        ISSN: 1507-1367


  27 in total

1.  On the role of the optimization algorithm of RapidArc(®) volumetric modulated arc therapy on plan quality and efficiency.

Authors:  Eugenio Vanetti; Giorgia Nicolini; Janne Nord; Jarkko Peltola; Alessandro Clivio; Antonella Fogliata; Luca Cozzi
Journal:  Med Phys       Date:  2011-11       Impact factor: 4.071

2.  Volumetric modulated arc therapy: IMRT in a single gantry arc.

Authors:  Karl Otto
Journal:  Med Phys       Date:  2008-01       Impact factor: 4.071

3.  Single-Arc IMRT?

Authors:  Thomas Bortfeld; Steve Webb
Journal:  Phys Med Biol       Date:  2008-12-10       Impact factor: 3.609

4.  Commissioning of volumetric modulated arc therapy (VMAT).

Authors:  James L Bedford; Alan P Warrington
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-02-01       Impact factor: 7.038

Review 5.  [Intensity-modulated radiotherapy in cervical cancer: towards a new standard?].

Authors:  R Mazeron; I Dumas; C El Khouri; A Lévy; M Attar; C Haie-Meder
Journal:  Cancer Radiother       Date:  2014-01-21       Impact factor: 1.018

6.  Intensity-modulated whole pelvic radiotherapy provides effective dosimetric outcomes for cervical cancer treatment with lower toxicities.

Authors:  Y Lv; F Wang; L Yang; G Sun
Journal:  Cancer Radiother       Date:  2014-11-18       Impact factor: 1.018

7.  Comparitive study of efficacy, tolerability of four field box technique vs. two field anterior posterior technique in locally advanced carcinoma cervix--a prospective analysis.

Authors:  Deepak Gupta; Pragya Shukla; Shyam Singh Bisht; Aditi Aggarwal; Ankur Dhawan; Mohan Chand Pant; Madan Lal Bhatt; Rajeev Gupta; Kirti Srivastava; Seema Gupta; Madhu Srivastava
Journal:  Cancer Biol Ther       Date:  2009-05-08       Impact factor: 4.742

8.  Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy in postoperative treatment of endometrial and cervical cancer.

Authors:  William Small; Loren K Mell; Penny Anderson; Carien Creutzberg; Jennifer De Los Santos; David Gaffney; Anuja Jhingran; Lorraine Portelance; Tracey Schefter; Revathy Iyer; Mahesh Varia; Kathryn Winter; Arno J Mundt
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-11-26       Impact factor: 7.038

9.  Influence of photon energy on the quality of prostate intensity modulated radiation therapy plans based on analysis of physical indices.

Authors:  Sundaram Thangavelu; S Jayakumar; K N Govindarajan; Sanjay S Supe; V Nagarajan; M Nagarajan
Journal:  J Med Phys       Date:  2011-01

10.  Evaluation of the analytical anisotropic algorithm in an extreme water-lung interface phantom using Monte Carlo dose calculations.

Authors:  Isabelle M Gagné; Sergei Zavgorodni
Journal:  J Appl Clin Med Phys       Date:  2006-06-16       Impact factor: 2.102

View more
  3 in total

1.  Effect of contrast medium on treatment modalities planned with different photon beam energies: a planning study.

Authors:  Manindra Bhushan; Deepak Tripathi; Girigesh Yadav; Lalit Kumar; Abhinav Dewan; Sarthak Tandon; Gourav Kumar; Inderjit Kaur Wahi; Munish Gairola
Journal:  Rep Pract Oncol Radiother       Date:  2021-09-30

2.  Impact of nominal photon energies on normal tissue sparing in knowledge-based radiotherapy treatment planning for rectal cancer patients.

Authors:  Yuliang Huang; Sha Li; Haizhen Yue; Meijiao Wang; Qiaoqiao Hu; Haiyang Wang; Tian Li; Chenguang Li; Hao Wu; Yibao Zhang
Journal:  PLoS One       Date:  2019-03-07       Impact factor: 3.240

3.  Reducing variability among treatment machines using knowledge-based planning for head and neck, pancreatic, and rectal cancer.

Authors:  Hideaki Hirashima; Mitsuhiro Nakamura; Nobutaka Mukumoto; Ryo Ashida; Kota Fujii; Kiyonao Nakamura; Aya Nakajima; Katsuyuki Sakanaka; Michio Yoshimura; Takashi Mizowaki
Journal:  J Appl Clin Med Phys       Date:  2021-06-20       Impact factor: 2.102

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.